Epidemiology of Sleep Disturbances and Cardiovascular Consequences

Canadian Journal of Cardiology

Volumn 31, Issue 7, 2015, Pages 873-879

  Badran, Mohammad ^a   Yassin, Bishr Abu ^a   Fox, Nurit ^b   Laher, Ismail ^a   Ayas, Najib ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ACUTE HEART INFARCTION; AGE; AORTA DISEASE; AORTA DISSECTION; APNEA HYPOPNEA INDEX; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS SURGERY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; HYPERTENSION; LIPID STORAGE; LUNG VOLUME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXYGEN DESATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSTMENOPAUSE; PREVALENCE; REVIEW; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLEEP TIME; WEIGHT GAIN; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; HEALTH; MORBIDITY; RISK FACTOR; SLEEP DISORDERS;

CARDIOVASCULAR DISEASES; GLOBAL HEALTH; HUMANS; MORBIDITY; RISK FACTORS; SLEEP DISORDERS;

EID: 84937634094     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.03.011     Document Type: Review

References (77)

1. Badran M., Ayas N., Laher I. Insights into obstructive sleep apnea research. Sleep Med 2014, 15:485-495.
2. Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep 1997, 20:406-422.
3. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165:1217-1239.
4. Badran M., Golbidi S., Badran M., Ayas N., Laher I. Cardiovascular consequences of sleep apnea. Lung 2012, 190:113-132.
5. Ayas N.T., Fox J., Epstein L., Ryan C.F., Fleetham J.A. Initial use of portable monitoring versus polysomnography to confirm obstructive sleep apnea in symptomatic patients: an economic decision model. Sleep Med 2010, 11:320-324.
6. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 32:1230-1235.
7. Peppard P.E., Young T., Barnet J.H., et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013, 177:1006-1014.
8. Durán J., Esnaola S., Rubio R., et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001, 163:685-689.
9. Ip M.S., Lam B., Lauder I.J., et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 2001, 119:62-69.
10. Ancoli-Israel S., Kripke D.F., Klauber M.R., et al. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991, 14:486-495.
11. Young T., Evans L., Finn L., Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997, 20:705-706.
12. Gibson G.J. Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull 2004, 72:49-65.
13. AlGhanim N., Comondore V.R., Fleetham J., Marra C.A., Ayas N.T. The economic impact of obstructive sleep apnea. Lung 2008, 186:7-12.
14. Stanchina M.L., Malhotra A., Fogel R.B., et al. The influence of lung volume on pharyngeal mechanics, collapsibility, and genioglossus muscle activation during sleep. Sleep 2003, 26:851-856.
15. Peppard P.E., Young T., Palta M., et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000, 284:3015-3021.
16. Mitchell L.J., Davidson Z.E., Bonham M., et al. Weight loss from lifestyle interventions and severity of sleep apnoea: a systematic review and meta-analysis. Sleep Med 2014, 15:1173-1183.
17. Brown M.A., Goodwin J.L., Silva G.E., et al. The impact of sleep-disordered breathing on body mass index (BMI): the Sleep Heart Health Study (SHHS). Southwest J Pulm Crit Care 2011, 3:159-168.
18. Young T., Finn L., Austin D., et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003, 167:1181-1185.
19. Bajuk Studen K., Jensterle Sever M., Pfeifer M. Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome. Front Horm Res 2013, 40:64-82.
20. Hoyos C.M., Killick R., Yee B.J., Grunstein R.R., Liu P.Y. Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial. Clin Endocrinol (Oxf) 2012, 77:599-607.
21. Liu P.Y., Yee B., Wishart S.M., et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003, 88:3605-3613.
22. Redline S., Tishler P.V., Hans M.G., et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med 1997, 155:186-192.
23. Lam B., Ip M.S., Tench E., et al. Craniofacial profile in Asian and white subjects with obstructive sleep apnea. Thorax 2005, 60:504-510.
24. White L.H., Bradley T.D. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol 2013, 591:1179-1193.
25. Palmer L.J., Buxbaum S.G., Larkin E.K., et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004, 169:1314-1321.
26. Pillar G., Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med 1995, 151:688-691.
27. Wetter D.W., Young T.B., Bidwell T.R., et al. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994, 154:2219-2224.
28. Scanlan M.F., Roebuck T., Little P.J., et al. Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J 2000, 6:909-913.
29. Finnimore A.J., Roebuck M., Sajkov D., et al. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995, 8:230-234.
30. Winkelman J.W., Goldman H., Piscatelli N., et al. Are thyroid function tests necessary in patients with suspected sleep apnea?. Sleep 1993, 19:790-793.
31. Fatti L.M., Scacchi M., Pincelli A.I., et al. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 2001, 4:259-262.
32. Fletcher E.C., DeBehnke R.D., Lovoi M.S., Gorin A.B. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985, 103:190-195.
33. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
34. Peppard P.E. Is obstructive sleep apnea a risk factor for hypertension? differences between the Wisconsin Sleep Cohort and the Sleep Heart Health Study. J Clin Sleep Med 2009, 5:404-405.
35. O'Connor G.T., Caffo B., Newman A.B., et al. Prospective study of sleep-disordered breathing and hypertension. Am J Respir Crit Care Med 2009, 179:1159-1164.
36. Gottlieb D.J., Punjabi N.M., Mehra R., et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 2014, 370:2276-2285.
37. Alajmi M., Mulgrew A.T., Fox J., et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185:67-72.
38. Haentjens P., Van Meerhaeghe A., Moscariello A., et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167:757-764.
39. Pamidi S., Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link?. Front Neurol 2012, 3:126.
40. Drager L.F., Li J., Reinke C., et al. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 2011, 19:2167-2174.
41. Louis M., Punjabi N.M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol (1985) 2009, 106:1538-1544.
42. Ayas N.T., Hirsch A.A., Laher I., et al. New frontiers in obstructive sleep apnoea. Clin Sci (Lond) 2014, 127:209-216.
43. Newman A.B., Nieto F.J., Guidry U., et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001, 154:50-59. Sleep Heart Health Study Research Group.
44. McArdle N., Hillman D., Beilin L., Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007, 175:190-195.
45. Drager L.F., Jun J., Polotsky V.Y. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2010, 17:161-165.
46. Nadeem R., Singh M., Nida M., et al. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 2014, 10:1295-1302.
47. Phillips C.L., Yee B., Marshall N.S., et al. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea. Am J Respir Crit Care Med 2011, 184:355-361.
48. Konecny T., Kuniyoshi F.H., Orban M., et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol 2010, 56:742-743.
49. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
50. Campos-Rodriguez F., Martinez-Garcia M.A., de la Cruz-Moron I., et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012, 156:115-122.
51. Kendzerska T., Gershon A.S., Hawker G., Leung R.S., Tomlinson G. Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med 2014, 11:e1001599.
52. Gottlieb D.J., Yenokyan G., Newman A.B., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010, 122:352-360.
53. McEvoy R.D., Anderson C.S., Antic N.A., et al. The sleep apnea cardiovascular endpoints (SAVE) trial: rationale and start-up phase. J Thorac Dis 2010, 2:138-143.
54. Drew D., Qaddoura A., Baranchuk A. The relationship between obstructive sleep apnea and atrial fibrillation in special patient populations. Expert Rev Cardiovasc Ther 2014, 12:1337-1348.
55. Yaranov D.M., Smyrlis A., Usatii N., et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol 2015, 115:461-465.
56. Naito R., Sakakura K., Kasai T., et al. Aortic dissection is associated with intermittent hypoxia and re-oxygenation. Heart Vessels 2012, 27:265-270.
57. Zhang X., Zhang T., Zhang X., et al. Obstructive sleep apnea syndrome: a risk factor for Stanford's type B aortic dissection. Ann Vasc Surg 2014, 28:1901-1908.
58. Mason R.H., Ruegg G., Perkins J., et al. Obstructive sleep apnea in patients with abdominal aortic aneurysms: highly prevalent and associated with aneurysm expansion. Am J Respir Crit Care Med 2011, 183:668-674.
59. National Sleep Foundation. Bedroom poll: summary of findings. Available at: Accessed November 1, 2014. http://sleepfoundation.org/sites/default/files/bedroompoll/NSF_Bedroom_Poll_Report.pdf.
60. Cappuccio F.P., D'Elia L., Strazzullo P., Miller M.A. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010, 33:585-592.
61. Cappuccio F.P., Cooper D., D'Elia L., Strazzullo P., Miller M.A. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011, 32:1484-1492.
62. Calvin A.D., Covassin N., Kremers W.K., et al. Experimental sleep restriction causes endothelial dysfunction in healthy humans. J Am Heart Assoc 2014, 3:e001143.
63. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
64. Meier-Ewert H.K., Ridker P.M., Rifai N., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004, 43:678-683.
65. Spiegel K., Tasali E., Penev P., et al. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
66. Patel S.R. Reduced sleep as an obesity risk factor. Obes Rev 2009, 10(suppl 2):61-68.
67. Nedeltcheva A.V., Kilkus J.M., Imperial J., Schoeller D.A., Penev P.D. Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med 2010, 153:435-441.
68. Ayas N.T., White D.P., Manson J.E., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003, 163:205-209.
69. Sands-Lincoln M., Loucks E.B., Lu B., et al. Sleep duration, insomnia, and coronary heart disease among postmenopausal women in the Women's Health Initiative. J Womens Health (Larchmt) 2013, 22:477-486.
70. Ikehara S., Iso H., Date C., et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 2009, 32:295-301.
71. Amagai Y., Ishikawa S., Gotoh T., et al. Sleep duration and incidence of cardiovascular events in a Japanese population: the Jichi Medical School cohort study. J Epidemiol 2010, 20:106-110.
72. Michal M., Wiltink J., Kirschner Y., et al. Complaints of sleep disturbances are associated with cardiovascular disease: results from the Gutenberg Health Study. PLoS One 2014, 9:e104324.
73. Rod N.H., Kumari M., Lange T., et al. The joint effect of sleep duration and disturbed sleep on cause-specific mortality: results from the Whitehall II cohort study. PLoS One 2014, 9:e91965.
74. Westerlund A., Bellocco R., Sundstrom J., et al. Sleep characteristics and cardiovascular events in a large Swedish cohort. Eur J Epidemiol 2013, 28:463-473.
75. Shankar A., Koh W.P., Yuan J.M., Lee H.P., Yu M.C. Sleep duration and coronary heart disease mortality among Chinese adults in Singapore: a population-based cohort study. Am J Epidemiol 2008, 168:1367-1373.
76. King C.R., Knutson K.L., Rathouz P.J., et al. Short sleep duration and incident coronary artery calcification. JAMA 2008, 300:2859-2866.
77. Li M., Zhang X.W., Hou W.S., Tang Z.Y. Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol 2014, 176:1044-1047.